
HCPCS Codes - ASP Reporting is done in Units not NDC
July 26th, 2017 - Chris Woolstenhulme, CPC, CMRS 0 Votes - Sign in to vote or comment. |
HCPCS CODES FOR WHICH ASP REPORTING IS DONE IN UNITS OF MEASURE OTHER THAN AN NDC Updated November 14, 2016
A9587 GALLIUM GA-68, DOTATATE, DIAGNOSTIC, 0.1 MILLICURIE 0.1 millicurie
A9588FLUCICLOVINE F-18, DIAGNOSTIC, 1 MILLICURIE 1 millicurie
A9606 RADIUM RA-223 DICHLORIDE, THERAPEUTIC, PER MICROCURIE 1 microcurie
C9132 PROTHROMBIN COMPLEX CONCENTRATE (HUMAN), KCENTRA, PER I.U. OF FACTOR IX ACTIVITY 1 IU
C9140 INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) (AFSTYLA), 1 I.U. 1 IU
J0256 INJECTION, ALPHA 1 PROTEINASE INHIBITOR (HUMAN), NOT OTHERWISE SPECIFIED, 10 MG 1 MG
J0257 INJECTION, ALPHA 1 PROTEINASE INHIBITOR (HUMAN), (GLASSIA), 10 MG 1 MG
J7175 INJECTION, FACTOR X, (HUMAN), 1 I.U. 1 IU
J7179 INJECTION, VON WILLEBRAND FACTOR (RECOMBINANT), (VONVENDI), 1 I.U. VWF:RCO 1 I.U. VWF:RCO
J7180 INJECTION, FACTOR XIII (ANTIHEMOPHILIC FACTOR, HUMAN), 1 I.U. 1 IU
J7181 INJECTION, FACTOR XIII A-SUBUNIT, (RECOMBINANT), PER IU 1 IU
J7182 FACTOR VIII, (ANTIHEMOPHILIC FACTOR, RECOMBINANT), (NOVOEIGHT), PER IU 1 IU
J7183 INJECTION, VON WILLEBRAND FACTOR COMPLEX (HUMAN), WILATE, 1 I.U. VWF:RCO 1 IU VWF:RCO
J7185 INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) (XYNTHA), PER I.U. 1 IU
J7186 INJECTION, ANTIHEMOPHILIC FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX (HUMAN), PER FACTOR VIII I.U. 1 IU
J7187 INJECTION, VON WILLEBRAND FACTOR COMPLEX (HUMATE-P), PER IU VWF:RCO 1 IU VWF:RCO
J7188 INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT), (OBIZUR), PER I.U. 1 IU
J7190 FACTOR VIII (ANTIHEMOPHILIC FACTOR, HUMAN) PER I.U. 1 IU
J7192 FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) PER I.U., NOT OTHERWISE SPECIFIED 1 IU
J7193 FACTOR IX (ANTIHEMOPHILIC FACTOR, PURIFIED, NON-RECOMBINANT) PER I.U. 1 IU
J7194 FACTOR IX, COMPLEX, PER I.U. 1 IU
J7195 INJECTION, FACTOR IX (ANTIHEMOPHILIC FACTOR, RECOMBINANT) PER IU, NOT OTHERWISE SPECIFIED 1 IU
J7196 INJECTION, ANTITHROMBIN RECOMBINANT, 50 I.U. 1 IU
J7197 ANTITHROMBIN III (HUMAN), PER I.U. 1 IU
J7198 ANTI-INHIBITOR, PER I.U. 1 IU
J7199 HEMOPHILIA CLOTTING FACTOR, NOT OTHERWISE CLASSIFIED 1 IU
J7200 FACTOR IX (ANTIHEMOPHILIC FACTOR, RECOMBINANT), RIXUBIS, PER I.U 1 IU
J7201 INJECTION, FACTOR IX, FC FUSION PROTEIN, (RECOMBINANT), ALPROLIX, 1 IU 1 IU
J7202 INJECTION, FACTOR IX, ALBUMIN FUSION PROTEIN (RECOMBINANT), IDELVION, 1 I.U. 1 IU
J7205 INJECTION, FACTOR VIII, FC FUSION PROTEIN (RECOMBINANT), PER IU 1 IU
J7207 INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) PEGYLATED, 1 I.U. 1 IU
J7209 INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) (NUWIQ), 1 I.U. 1 IU
###
Questions, comments?
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
Latest articles: (any category)
How to Combat COVID-Related Risk Adjustment Losses with the Medicare Annual Wellness ExamApril 12th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
April 12th, 2021 - Wyn Staheli, Director of Research
April 8th, 2021 - Aimee Wilcox CPMA, CCS-P, CST, MA, MT and Wyn Staheli, Director of Content Research
March 31st, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
March 23rd, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
March 18th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
March 10th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS